Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance is a research paper published in Angewandte Chemie International Edition (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: S10 OD021536
National Institute of General Medical Sciences
Grant: S10 OD023524
National Institute of General Medical Sciences
Grant: R01 GM041376
National Institute of Allergy and Infectious Diseases
Grant: R01 AI132374
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Grant: U19 AI142731
NIGMS NIH HHS
Grant: R37 GM041376
FWCI
1.84
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals